We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVO icon
1326
Mission Produce
AVO
$1.17B
$12K ﹤0.01%
706
BLNK icon
1327
Blink Charging
BLNK
$87.9M
$12K ﹤0.01%
422
CLNE icon
1328
Clean Energy Fuels
CLNE
$346M
$12K ﹤0.01%
1,540
LFCR icon
1329
Lifecore Biomedical
LFCR
$190M
$12K ﹤0.01%
1,330
NIO icon
1330
NIO
NIO
$11.9B
$12K ﹤0.01%
364
PASG icon
1331
Passage Bio
PASG
$14.1M
$12K ﹤0.01%
62
SFM icon
1332
Sprouts Farmers Market
SFM
$8.01B
$12K ﹤0.01%
552
SIGA icon
1333
SIGA Technologies
SIGA
$219M
$12K ﹤0.01%
1,715
-15
-0.9% -$96
TBPH icon
1334
Theravance Biopharma
TBPH
$877M
$12K ﹤0.01%
1,685
+200
+13% +$2.24K
TPIC
1335
DELISTED
TPI Composites
TPIC
$12K ﹤0.01%
376
VSTM icon
1336
Verastem
VSTM
$610M
$12K ﹤0.01%
344
+18
+6% +$661
VIVO
1337
VivoPower PLC
VIVO
$124M
$12K ﹤0.01%
222
GTHX
1338
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$12K ﹤0.01%
965
+5
+0.5% +$81
CLVS
1339
DELISTED
Clovis Oncology, Inc.
CLVS
$12K ﹤0.01%
2,705
+325
+14% +$1.56K
AERI
1340
DELISTED
Aerie Pharmaceuticals
AERI
$12K ﹤0.01%
1,080
+15
+1% +$219
REGI
1341
DELISTED
Renewable Energy Group, Inc.
REGI
$12K ﹤0.01%
248
AKBA icon
1342
Akebia Therapeutics
AKBA
$252M
$11K ﹤0.01%
3,995
+350
+10% +$999
CBUS icon
1343
Cibus
CBUS
$138M
$11K ﹤0.01%
69
CGEN icon
1344
Compugen
CGEN
$228M
$11K ﹤0.01%
1,920
+15
+0.8% +$100
LKFT
1345
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$11K ﹤0.01%
215
+50
+30% +$2.97K
KNDI
1346
Kandi Technologies Group
KNDI
$65.5M
$11K ﹤0.01%
2,616
MED icon
1347
Medifast
MED
$141M
$11K ﹤0.01%
58
-8,449
-99% -$2.08M
NIU
1348
Niu Technologies
NIU
$193M
$11K ﹤0.01%
486
SMMT icon
1349
Summit Therapeutics
SMMT
$11.1B
$11K ﹤0.01%
2,225
+10
+0.5% +$72
SOL
1350
DELISTED
Emeren Group
SOL
$11K ﹤0.01%
1,762

Similar funds

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.